Review: taking Citalopram hydrobromide and Omeprazole together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Omeprazole together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Omeprazole. It is created by eHealthMe based on reports of 9,404 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 25,688 users)

Omeprazole

Omeprazole has active ingredients of omeprazole. It is often used in gastrooesophageal reflux disease. (latest outcomes from Omeprazole 154,416 users)

On Sep, 18, 2016

9,404 people who take Citalopram Hydrobromide, Omeprazole are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Omeprazole drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 33.0% - (3 of 9 people)
  • 1 - 6 months: 28.0% - (11 of 39 people)
  • 6 - 12 months: 70.0% - (14 of 20 people)
  • 1 - 2 years: 42.0% - (14 of 33 people)
  • 2 - 5 years: 47.0% - (22 of 46 people)
  • 5 - 10 years: 44.0% - (12 of 27 people)
  • 10+ years: 55.0% - (10 of 18 people)
  • not specified: 0.0% - (0 of 4 people)
Omeprazole:
  • < 1 month: 20.0% - (4 of 20 people)
  • 1 - 6 months: 50.0% - (11 of 22 people)
  • 6 - 12 months: 38.0% - (7 of 18 people)
  • 1 - 2 years: 75.0% - (25 of 33 people)
  • 2 - 5 years: 74.0% - (35 of 47 people)
  • 5 - 10 years: 77.0% - (35 of 45 people)
  • 10+ years: 78.0% - (15 of 19 people)
  • not specified: 25.0% - (1 of 4 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 43.0% - (60 of 139 people)
  • male: 45.0% - (26 of 57 people)
Omeprazole:
  • female: 58.0% - (86 of 148 people)
  • male: 78.0% - (47 of 60 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 25.0% - (1 of 4 people)
  • 20-29: 50.0% - (7 of 14 people)
  • 30-39: 46.0% - (14 of 30 people)
  • 40-49: 40.0% - (18 of 44 people)
  • 50-59: 46.0% - (21 of 45 people)
  • 60+: 42.0% - (25 of 59 people)
Omeprazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 5 people)
  • 20-29: 71.0% - (10 of 14 people)
  • 30-39: 64.0% - (20 of 31 people)
  • 40-49: 68.0% - (35 of 51 people)
  • 50-59: 71.0% - (33 of 46 people)
  • 60+: 57.0% - (35 of 61 people)

Most common drug interactions over time *:

< 1 month:
  • vomiting
  • confusional state
  • overdose
  • headache
  • hyponatraemia
  • suicide attempt
  • diarrhoea
  • hallucination
  • rheumatoid arthritis
  • serotonin syndrome
1 - 6 months:
  • malaise
  • cough
  • syncope
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • depression
  • back pain
  • loss of consciousness
  • coronary arterial stent insertion
  • heart rate irregular
6 - 12 months:
  • anxiety
  • pain
  • activated partial thromboplastin time abnormal
  • arteriosclerosis coronary artery
  • coronary artery stenosis
  • myocardial fibrosis
  • myocardial ischaemia
  • pulmonary oedema
  • hip fracture
  • osteopenia
1 - 2 years:
  • depression
  • nausea
  • muscle spasms
  • renal failure acute
  • vomiting
  • dehydration
  • depressed level of consciousness
  • drug level increased
  • fall
  • serotonin syndrome
2 - 5 years:
  • depression
  • diarrhoea
  • abdominal pain
  • muscle spasms
  • anxiety
  • impaired healing
  • vomiting
  • chest pain
  • colonic polyp
  • haemorrhoids
5 - 10 years:
  • confusion
  • drug level increased
  • hyponatraemia
  • syncope
  • death
  • depression
  • arthralgia
  • dehydration
  • fatigue
  • haemorrhoidal haemorrhage
10+ years:
  • pain in extremity
  • osteoporosis
  • foot fracture
  • pain
  • mental disorder
  • osteopenia
  • myalgia
  • osteoarthritis
  • depression
  • back pain
not specified:
  • pain
  • nausea
  • fatigue
  • anxiety
  • dyspnoea
  • fall
  • diarrhoea
  • depression
  • vomiting
  • headache

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • anxiety
  • fatigue
  • fall
  • diarrhoea
  • depression
  • vomiting
  • dyspnoea
  • pain in extremity
male:
  • pain
  • dyspnoea
  • fatigue
  • nausea
  • pneumonia
  • anxiety
  • asthenia
  • depression
  • diarrhoea
  • fall

Most common drug interactions by age *:

0-1:
  • premature baby
  • drug withdrawal syndrome neonatal
  • cognitive disorder
  • gait disturbance
  • hypocalcaemia
  • neonatal respiratory distress syndrome
  • pneumothorax
  • urinary tract infection
  • abnormal behaviour
  • bradykinesia
2-9:
  • vomiting
  • depression
  • dysphemia
  • nausea
  • anaemia
  • emotional distress
  • eye disorder
  • hypertension
  • injury
  • pain
10-19:
  • intentional overdose
  • pain
  • anxiety
  • chest pain
  • suicide attempt
  • drug ineffective
  • malaise
  • mydriasis
  • tremor
  • agitation
20-29:
  • pain
  • vomiting
  • abdominal pain
  • anxiety
  • depression
  • headache
  • nausea
  • pulmonary embolism
  • deep vein thrombosis
  • injury
30-39:
  • pain
  • depression
  • anxiety
  • nausea
  • vomiting
  • fatigue
  • pulmonary embolism
  • abdominal pain
  • asthenia
  • fall
40-49:
  • pain
  • anxiety
  • nausea
  • depression
  • fatigue
  • vomiting
  • diarrhoea
  • dizziness
  • gastrooesophageal reflux disease
  • headache
50-59:
  • pain
  • nausea
  • anxiety
  • diarrhoea
  • fatigue
  • arthralgia
  • anaemia
  • fall
  • headache
  • dyspnoea
60+:
  • fall
  • dyspnoea
  • fatigue
  • diarrhoea
  • nausea
  • pain
  • pneumonia
  • asthenia
  • dizziness
  • vomiting

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Omeprazole?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Omeprazole

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Omeprazole

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Omeprazole (omeprazole) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.